Top Medical News
2 hours ago
Intravenous terlipressin infusion appears to be the most effective medical therapy for reversing hepatorenal syndrome, while intravenous noradrenaline infusion is an acceptable alternative, according to a study.
Metformin therapy appears to significantly improve prognosis in patients with colon cancer and survival in patients with lung cancer, a new study has shown.
2 days ago
Fructans exacerbate several symptoms of irritable bowel syndrome (IBS) in children, a study has shown. However, those with fructan sensitivity cannot be identified based on baseline gastrointestinal symptoms, dietary intake, psychosocial factors or gas production.
Dr. Joseph Delano Fule Robles, 2 days ago

A study recently conducted by the Chinese University of Hong Kong (CUHK) in collaboration with the University of Calgary, Alberta, Canada, revealed a trend of increasing incidence of inflammatory bowel disease (IBD) including ulcerative colitis (UC) and Crohn’s disease (CD) in regions other that the West, with the incidence in Hong Kong increasing more than 30 times over the past 30 years.

Jairia Dela Cruz, 3 days ago
Having both type 1 diabetes and coeliac disease (CD) autoimmunity in early childhood appears to be more common than expected, with the development of islet autoantibodies (IAs) conferring a significant risk of subsequent tissue transglutaminase autoantibodies (tTGAs), according to data from the TEDDY* study.
4 days ago
Pancreatoscopy is effective and well tolerated in patients with difficult to manage stone disease, strictures and possible malignant ductal pathology, facilitating both diagnosis and therapy, according to a recent study.
5 days ago
Patients with inflammatory bowel disease (IBD) have generally lower levels of fat-soluble vitamins (A, D, E and K), a recent study has found, which suggests the need for their supplementation.
Special Reports
09 Oct 2017
In this issue of MIMS Gastroenterology Supplement, we bring you clinical updates related to hepatitis B, and also a symposium highlight in conjunction with the launch of tenofovir disoproxil fumarate (Ricovir®; Mylan Laboratories) in Malaysia.  
29 Sep 2017
Nonalcoholic fatty liver disease (NAFLD), including simple steatosis and nonalcoholic steatohepatitis (NASH), is widely considered as the liver manifestation of the metabolic syndrome. It is a major cause of liver disease worldwide and its prevalence is expected to rise in tandem with the rising prevalence of obesity and diabetes mellitus. Recently, MIMS Doctor spoke to Associate Professor Dr Wah Kheong Chan, a Consultant Physician and Gastroenterologist at the University of Malaya Medical Centre and University of Malaya Specialist Centre, to provide an update on NAFLD, with a particular emphasis on the use of silymarin for the treatment of NASH. Here are the highlights from the interview. 
29 Sep 2017
Constipation is a common disorder which adversely affects the wellbeing and quality of life of patients.1 Recently, MIMS Doctor spoke to Associate Prof Dr Raja Affendi Raja Ali on the landscape of constipation in Malaysia, emphasizing on effective and early management of the condition.
12 Jul 2017
DUKORAL – Inactivated Vibrio cholerae O1 serogroup & recombinant cholera toxin B subunit (WC/rCTB) vaccine (oral) – AJ Biologics
20 Mar 2017
At the recent Asian Pacific Digestive Week (APDW) 2016 held in Kobe, Japan, three prominent international experts shared their views on gastroesophageal reflux disease (GERD) and the challenges of its management.
04 Jan 2017
Recently, randomized controlled trials and guidelines have brought to light the benefits of extending the duration of H. pylori treatment. Below are summaries of guidelines and trials examining the regimens used to manage the infection.
14 Dec 2016
At the recent Annual Scientific Congress of the Malaysian Society of Gastroenterology and Hepatology (GUT 2016), held at Shangri-La Hotel, Kuala Lumpur, an expert from Hong Kong spoke on the role of direct-acting antivirals as well as pan-genotypic agents that are set to revolutionize hepatitis C treatment.
Conference Reports
Dr. Joseph Delano Fule Robles, 10 Oct 2017

A recent study from China showed that faecal microbiota transplantation (FMT) is effective as a therapeutic option for patients with inflammatory bowel disease (IBD).

Naomi Rodrig, 09 Oct 2017

New endoscopic technologies have improved outcomes for patients with upper gastrointestinal bleeding (UGIB), according to Professor James Lau from the Chinese University of Hong Kong, who reviewed current treatment practices and latest advances at the Asian Pacific Digestive Week (APDW) 2017 held recently in Hong Kong.

Elaine Tan, 04 Oct 2017

Sodium phosphate (NaP) tablets for bowel preparation prior to colonoscopy are safe, better tolerated by patients, and provide equivalent and possibly superior colon cleansing compared with standard polyethylene glycol (PEG) solution, a Korean study has found.

Elaine Tan, 04 Oct 2017

Functional cure of hepatitis B virus (HBV) infection could be possible in the near future with the development of drugs that inhibit HBV replication, recent early-phase clinical studies have shown.

04 Oct 2017
Slideshow: Highlights from the Asia Pacific Digestive Week 2017 (APDW 2017)
Jenny Ng, 04 Oct 2017

Genotypic resistance-guided therapy is no better than traditional empiric therapy for treating patients with refractory Helibacter pylori infection. Researchers found no significant difference in eradication rate between the two strategies when used in the third-line setting.

Jenny Ng, 04 Oct 2017

Researchers are setting their sights high on immunotherapy as a promising strategy in advanced pancreatic cancer, with several agents currently in development. 

CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!